Mo. ° / °
    Ariz. ° / °
    Calif. ° / °
ATSU Continuing Education
 

december, 2021

17dec12:00 pm1:00 pmLet's Talk About OMM Research Series! | Episode 15Let's Talk About OMM Research! | Episode 15

more

Event Details

Let’s Talk About OMM Research! Virtual Series

EPISODE 15 | Journal Club: Review and Discussion

The global summit on the efficacy and effectiveness of spinal manipulative therapy for the prevention and treatment of non-musculoskeletal disorders: a systematic review of the literature

Dec. 17, 2021 | 12:00 p.m. – 1:00 p.m. (CST)

Click MORE for program information and tuition pricing.

TUITION PRICING

*1 AOA Category 1-A Credits

  • Non-DO-Touch.NET Members: $30
  • DO-Touch.NET Members: $15 (with discount code)

 

SAVE THE DATE! 
Mark your calendars and plan to attend!

COURSE INFORMATION

Course Description
Sessions will include presentations of the latest scientific evidence regarding osteopathic manipulative medicine (OMM) and topics related to OMM research and practice within the field. Sessions are designed to encourage discussion about evidence and topics presented.

Educational Objectives

  • Provide examples of recent research findings on osteopathic manipulative medicine which they could apply to their clinical practice.
  • Interpret current evidence regarding osteopathic manipulative medicine.
  • Recognize research opportunities in osteopathic manipulative medicine.

Target Audience
Osteopathic physicians and international osteopathic clinicians who are members of DO-Touch.NET.

Professional Practice Gap
Practitioners of osteopathic manipulative medicine need to be reminded what is and is not evidenced-based within the current practice of OMM. This requires keeping informed about the latest research, evaluating the strengths and weaknesses of this research. Additionally, they need to recognize how they can apply the current evidence regarding osteopathic manipulative medicine in their clinical practice and learn ways to personally contribute to the science being done in the field.

Educational Need
There are frequent advancements in the evidence base for osteopathic manipulative medicine and for manual therapy in general. Clinicians need to stay informed of the latest evidence.
Informal comments from DO-Touch.NET members indicate that there is the need to keep up with the current research on osteopathic manipulative medicine.

Desired Outcomes
Participants will have expanded knowledge about the current evidence regarding the use, effectiveness, and safety of osteopathic manipulative medicine. They will recognize how they can apply the current evidence to their clinical practice of osteopathic manipulative medicine.

Accreditation Statement
A.T. Still University is accredited by the American Osteopathic Association to provide osteopathic continuing medical education programs for physicians.

ATSU designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Call the ATSU CE Office at 660-626-2232 for more information.

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Time

(Friday) 12:00 pm - 1:00 pm CST

Location

VIRTUAL SERIES

Organizer

DO-Touch.NETSara Amini-Rad, MPH, CHES | 660.626.2101 | dotouchnet@atsu.edu

Comments are closed.


X